223 related articles for article (PubMed ID: 32923157)
1. B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma.
Minici C; Rigamonti E; Lanzillotta M; Monno A; Rovati L; Maehara T; Kaneko N; Deshpande V; Protti MP; De Monte L; Scielzo C; Crippa S; Arcidiacono PG; Dugnani E; Piemonti L; Falconi M; Pillai S; Manfredi AA; Della-Torre E
Oncoimmunology; 2020 Jul; 9(1):1794359. PubMed ID: 32923157
[TBL] [Abstract][Full Text] [Related]
2. B lymphocytes directly contribute to tissue fibrosis in patients with IgG
Della-Torre E; Rigamonti E; Perugino C; Baghai-Sain S; Sun N; Kaneko N; Maehara T; Rovati L; Ponzoni M; Milani R; Lanzillotta M; Mahajan V; Mattoo H; Molineris I; Deshpande V; Stone JH; Falconi M; Manfredi AA; Pillai S
J Allergy Clin Immunol; 2020 Mar; 145(3):968-981.e14. PubMed ID: 31319101
[TBL] [Abstract][Full Text] [Related]
3. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC).
Lianyuan T; Dianrong X; Chunhui Y; Zhaolai M; Bin J
Cancer Biol Ther; 2018 Apr; 19(4):296-305. PubMed ID: 29313457
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast activation protein-α-expressing fibroblasts promote the progression of pancreatic ductal adenocarcinoma.
Kawase T; Yasui Y; Nishina S; Hara Y; Yanatori I; Tomiyama Y; Nakashima Y; Yoshida K; Kishi F; Nakamura M; Hino K
BMC Gastroenterol; 2015 Sep; 15():109. PubMed ID: 26330349
[TBL] [Abstract][Full Text] [Related]
5. The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications.
Liu X; Xu J; Zhang B; Liu J; Liang C; Meng Q; Hua J; Yu X; Shi S
Mol Cancer; 2019 Dec; 18(1):184. PubMed ID: 31831007
[TBL] [Abstract][Full Text] [Related]
6. Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma.
Busek P; Vanickova Z; Hrabal P; Brabec M; Fric P; Zavoral M; Skrha J; Kmochova K; Laclav M; Bunganic B; Augustyns K; Van Der Veken P; Sedo A
Pancreatology; 2016; 16(5):829-38. PubMed ID: 27320722
[TBL] [Abstract][Full Text] [Related]
7. B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma.
Minici C; Testoni S; Della-Torre E
Front Immunol; 2022; 13():867902. PubMed ID: 35359944
[TBL] [Abstract][Full Text] [Related]
8. Extracellular matrix-mediated membrane-type 1 matrix metalloproteinase expression in pancreatic ductal cells is regulated by transforming growth factor-beta1.
Ottaviano AJ; Sun L; Ananthanarayanan V; Munshi HG
Cancer Res; 2006 Jul; 66(14):7032-40. PubMed ID: 16849548
[TBL] [Abstract][Full Text] [Related]
9. Generation of an in vitro 3D PDAC stroma rich spheroid model.
Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
[TBL] [Abstract][Full Text] [Related]
10. Novel stromal biomarker screening in pancreatic cancer patients using the in vitro cancer-stromal interaction model.
Nishida Y; Nagatsuma AK; Kojima M; Gotohda N; Ochiai A
BMC Gastroenterol; 2020 Dec; 20(1):411. PubMed ID: 33297976
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role of microRNA-29 in pancreatic cancer stroma.
Kwon JJ; Nabinger SC; Vega Z; Sahu SS; Alluri RK; Abdul-Sater Z; Yu Z; Gore J; Nalepa G; Saxena R; Korc M; Kota J
Sci Rep; 2015 Jun; 5():11450. PubMed ID: 26095125
[TBL] [Abstract][Full Text] [Related]
12. Arachidonate 12-lipoxygenase and 12-hydroxyeicosatetraenoic acid contribute to stromal aging-induced progression of pancreatic cancer.
Sarsour EH; Son JM; Kalen AL; Xiao W; Du J; Alexander MS; O'Leary BR; Cullen JJ; Goswami PC
J Biol Chem; 2020 May; 295(20):6946-6957. PubMed ID: 32265301
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming pancreatic stellate cells via p53 activation: A putative target for pancreatic cancer therapy.
Saison-Ridinger M; DelGiorno KE; Zhang T; Kraus A; French R; Jaquish D; Tsui C; Erikson G; Spike BT; Shokhirev MN; Liddle C; Yu RT; Downes M; Evans RM; Saghatelian A; Lowy AM; Wahl GM
PLoS One; 2017; 12(12):e0189051. PubMed ID: 29211796
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma.
Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM
J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Transition of Pancreatic Ductal Cell Adenocarcinoma Is Accompanied by the Emergence of Pro-Invasive Cancer-Associated Fibroblasts.
Liu S; Suhail Y; Novin A; Perpetua L; Kshitiz
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565326
[TBL] [Abstract][Full Text] [Related]
17. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
18. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer.
Hartmann N; Giese NA; Giese T; Poschke I; Offringa R; Werner J; Ryschich E
Clin Cancer Res; 2014 Jul; 20(13):3422-33. PubMed ID: 24763614
[TBL] [Abstract][Full Text] [Related]
19. Noninvasive Young's modulus visualization of fibrosis progression and delineation of pancreatic ductal adenocarcinoma (PDAC) tumors using Harmonic Motion Elastography (HME)
Nabavizadeh A; Payen T; Iuga AC; Sagalovskiy IR; Desrouilleres D; Saharkhiz N; Palermo CF; Sastra SA; Oberstein PE; Rosario V; Kluger MD; Schrope BA; Chabot JA; Olive KP; Konofagou EE
Theranostics; 2020; 10(10):4614-4626. PubMed ID: 32292518
[No Abstract] [Full Text] [Related]
20. Pancreatic Tumor Microenvironment.
Wang K; He H
Adv Exp Med Biol; 2020; 1296():243-257. PubMed ID: 34185297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
